In recent years, China has made remarkable strides in the global field of vascular intervention technology. Spearheaded by leading experts like Professor Shu Chang, these innovations are setting new standards in the treatment of complex vascular diseases.

Breakthrough in Aortic Arch Reconstruction with the Concave Supra System

One of the most significant innovations is the Concave Supra-arch Branched Stent-Graft system, developed by Professor Shu Chang’s team. This system features a unique concave design that adapts to the complex hemodynamics of the aortic arch and allows for the reconstruction of three branches within a short time frame. Clinical studies have shown that the system performs exceptionally well during surgery, with the shortest operation time being just 37 minutes. It also significantly reduces the risk of intraoperative complications such as stroke.

This groundbreaking technology has not only marked a new milestone in China’s capability to innovate in endovascular treatment but has also garnered international attention. At multiple international conferences, including CICE 2024, Professor Shu showcased the system’s success, discussing its clinical applications with experts from Germany, Argentina, and Brazil. These discussions have provided new insights and solutions for the global treatment of aortic diseases .

Successful Application of the CS Aortic Arch Branch Stent System

Another significant achievement is the development and successful clinical application of the CS Aortic Arch Branch Stent System by Fuwai Hospital. This system was designed to address the growing complexity of aortic aneurysms, particularly in patients with intricate aortic conditions. Its successful application in clinical settings has demonstrated its effectiveness and safety, laying the groundwork for broader adoption in the future .

Preoperative aortic CT scan

Left image: Preoperative 3D printing of patient's aortic model and simulation of in vitro implantation

Middle image: Postoperative contrast-enhanced image

Right image: Postoperative one week follow-up aortic CT scan

Accelerating International Promotion and Collaboration

As China’s vascular intervention technologies continue to mature, these innovations are rapidly entering international markets. Chinese experts, led by Professor Shu, are actively promoting these technologies through international exchanges and surgical demonstrations in countries such as Brazil and Thailand. These collaborations not only validate the effectiveness of China’s homegrown technologies but also strengthen cross-border medical exchanges, enhancing China’s influence in global medical innovation.

IAMSPE Hospital Surgical Tutoring

Conclusion

The achievements in vascular intervention technology in China reflect the nation’s growing ability to innovate domestically while also gaining widespread international recognition and application. These innovations are providing safer, more effective treatment options for cardiovascular patients worldwide and injecting new vitality into the development of global medical technologies. As these technologies continue to be promoted and applied, China’s influence in the global cardiovascular field is expected to expand further.